Index of reports
> Life Threatening Events (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ursodiol life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Ursodiol side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-05
Patient:
Reactions: Portal Hypertension, Gastrointestinal Haemorrhage, Shock Haemorrhagic, Hepatic Failure, Gastric Ulcer, Cerebral Haemorrhage, Haemodynamic Instability, Hepatitis Cholestatic, Oesophagitis, Truncus Coeliacus Thrombosis, Metabolic Acidosis, Cholecystitis Infective, Neurological Decompensation, Hepatic Fibrosis, Pancytopenia, Ascites, Renal Failure, Respiratory Failure, Sepsis, Oliguria, Cytomegalovirus Infection, Bone Marrow Toxicity, Infectious Peritonitis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ursodiol
Dosage: oral
Administration route: Oral
Indication: Cholestasis
Start date: 2011-07-01
End date: 2011-08-23
Azathioprine
Dosage: 125 mg, qd, oral
Administration route: Oral
Indication: Autoimmune Hepatitis
Start date: 2011-07-01
End date: 2011-08-23
Other drugs received by patient: Prednisone
|